Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 12, 2008, Pages 1401-1406

  Chan, P C ^a,b,c   Chang, L Y ^c   Wu, Y C ^a   Lu, C Yi ^c   Kuo, H S ^a   Lee, C Y ^c   Huang, Li Min ^c   Chen, Chien Jen ^b,d  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

BCG; Infants and children; Latent tuberculosis infection; Tuberculin skin test

Indexed keywords

BCG VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BCG VACCINATION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; AGE FACTORS; BCG VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION;

EID: 58049213335     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. World Health Organization. The stop TB strategy. WHO/HTM/STB/2006.368. Geneva, Switzerland: WHO, 2006.
2. Fine P E, Sterne J A, Ponnighaus J M, et al. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994; 344: 1245-1249.
3. Pediatric Tuberculosis Collaborative Group. Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics 2004; 114: 1175-1201.
4. Almeida L M, Barbieri M A, Da Paixao A C, et al. Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guérin bacillus coverage. Pediatr Infect Dis J 2001; 20: 1061-1065.
5. Mudido P M, Guwatudde D, Nakakeeto M K, et al. The effect of bacille Calmette-Guérin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis 1999; 3: 891-895.
6. Lockman S, Tappero J W, Kenyon T A, et al. Tuberculin reactivity in a pediatric population with high BCG vaccination coverage. Int J Tuberc Lung Dis 1999; 3: 23-30.
7. Fine P E, Bruce J, Ponnighaus J M, et al. Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis 1999; 3: 962-975.
8. Tanzania Tuberculin Survey Collaboration. Tuberculosis control in the era of the HIV epidemic: risk of tuberculosis infection in Tanzania, 1983-1998. Int J Tuberc Lung Dis 2001; 5: 103-112.
9. Lifschitz M. The value of the tuberculin skin test as a screening test for tuberculosis among BCG-vaccinated children. Pediatrics 1965; 36: 624-627.
10. Santiago E M, Lawson E, Gillenwater K, et al. A prospective study of bacillus Calmette-Guérin scar formation and tuberculin skin test reactivity in infants in Lima, Peru. Pediatrics 2003; 112: e298-e302.
11. Karalliedde S, Katugaha L P, Uragoda C G. Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 1987; 68: 33-38.
12. World Health Organization. BCG vaccine. WHO position paper. Wkly Epidemiol Rec 2004; 4: 27-28.
13. Provincial Chronic Disease Control Bureau. A review of the tuberculosis control program in Taiwan, 1949-1989: chronological development of the program, BCG vaccination. Taipei, Taiwan: Provincial Chronic Disease Control Bureau, 1991: pp 4-37.
14. Center for Disease Control. Tuberculosis annual report, 2001: strategies for tuberculosis control. Taipei, Taiwan: Center for Disease Control, 2001: pp 29-30.
15. World Health Organization. Guideline for national tuberculosis programmes on the management of tuberculosis in children. WHO/HTM/STB/2006.371. Geneva, Switzerland: WHO, 2006.
16. Comstock G W, Edwards L B, Philip R N, et al. A comparison in the United States of America of two tuberculins, PPD-S and PPD RT 23. Bull World Health Organ 1964; 31: 161-170.
17. Yeh Y P, Luh D L, Chang S H, et al. Tuberculin reactivity in adults after 50 years of universal bacilli Calmette-Guérin vaccination in Taiwan. Trans R Soc Trop Med Hyg 2005; 99: 509-516.
18. Comstock G W, Edwards L B, Nabangxang H. Tuberculin sensitivity eight to fifteen years after BCG vaccination. Am Rev Respir Dis 1971; 103: 572-575.
19. Horwitz O, Bunch-Christensen K. Correlation between tuberculin sensitivity after 2 months and 5 years among BCG-vaccinated subjects. Bull World Health Organ 1972; 47: 49-58.
20. Bowerman R J. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan. Int J Tuberc Lung Dis 2004; 8: 1228-1233.
21. Pickering L K. Tuberculosis. In: Red book, 2006 report of the Committee on Infectious Diseases. 27th ed. Elk Groove Village, IL, USA: American Academy of Pediatrics, 2006: pp 678-685.
22. Styblo K. The relationship between the risk of tuberculosis infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc 1985; 60: 117-119.
23. Arnadottir H, Rieder H L, Trébucq A, et al. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tubercle Lung Dis 1996; 77 (Suppl): 1-20.
24. Taiwan Centers for Disease Control. Manual of tuberculosis control. Taipei, Taiwan: CDC. http://203.65.72.43/feng/edu/index-1.htm Accessed September 2008.
25. Wang L, Turner M O, Elwood R K, et al. A meta-analysis of the effect of bacille Calmette-Guérin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804-809.
26. Mazurek G H, Villarino M E. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR 2003; 52: 15-18.
27. Mazurek G H, Jereb J, Lobue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR 2005; 54: 49-55.
28. Lalvani A, Pathan A A, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357: 2017-2021.
29. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173.
30. Kang Y A, Lee H W, Yoon H I, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293: 2756-2761.
31. Soysal A, Millington K A, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005; 366: 1443-1451.